Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Longitudinal Imaging Patterns and Corticosteroid Management in COVID-19 Patients with Pre-existing Interstitial Lung Disease: A 24-Month Cohort Analysis
Clinical Scorecard: Longitudinal Imaging Patterns and Corticosteroid Management in COVID-19 Patients with Pre-existing Interstitial Lung Disease: A 24-Month Cohort Analysis
At a Glance
Category
Detail
Condition
COVID-19 in patients with pre-existing interstitial lung disease (ILD)
Key Mechanisms
SARS-CoV-2 induces diffuse alveolar damage and activates profibrotic pathways, including TGF-β and PDGF signaling.
Target Population
Hospitalized COVID-19 patients with a pre-existing diagnosis of ILD.
Care Setting
Hospitalized patients, monitored through longitudinal imaging and clinical assessments.
Key Highlights
Patients with ILD have higher odds of ICU admission and in-hospital mortality during COVID-19.
SARS-CoV-2 may accelerate ILD activity and promote progressive fibrotic remodeling.
Corticosteroids are the cornerstone for managing acute inflammatory exacerbations in ILD.
Long-term structural consequences of COVID-19 in ILD patients are not well understood.
Optimal corticosteroid dosing and tapering duration post-COVID-19 remain undefined.
Guideline-Based Recommendations
Diagnosis
ILD diagnoses should be confirmed through clinical, radiologic, or histopathologic evidence.
Utilize a multidisciplinary discussion for ILD diagnosis and subtype classification.
Management
Corticosteroids should be used for acute inflammatory exacerbations in ILD.
Monitor corticosteroid tapering duration to assess impact on long-term outcomes.
Monitoring & Follow-up
High-resolution CT (HRCT) is essential for monitoring ILD progression over time.
Risks
Increased risk of post-infection exacerbations and functional decline in ILD survivors.
Patient & Prescribing Data
82 hospitalized patients with PCR-confirmed COVID-19 and pre-existing ILD.
Corticosteroid exposure and tapering duration may influence clinical and radiologic recovery.
Clinical Best Practices
Conduct regular HRCT assessments at baseline and follow-up intervals (6, 12, and 24 months).
Ensure diagnostic consistency through multidisciplinary review of ILD cases.
Heart rate monitoring and atrial fibrillation detection had the strongest supporting evidence, but investigators found limited evidence for broader outpatient self-monitoring applications.
The procedure was performed under a HOPE Act research protocol at an NYU Langone Health center the institution said is among the limited number of US transplant centers equipped and approved to perform HOPE lung transplants.
